Notification That Quarterly Report Will Be Submitted Late (nt 10-q)
December 16 2019 - 5:16PM
Edgar (US Regulatory)
United
States
Securities
and Exchange Commission
Washington,
D.C. 20549
Form
12b-25
Notification
of Late Filing
Commission File Number: 000-28132
CUSIP Number: 86323X106
(Check One):
|
¨ Form 10-K
|
¨
Form 20-F
|
¨
Form 11-K
|
x Form 10-Q
|
¨ Form
10-D
|
¨ Form
N-CEN
|
|
¨ Form
N-CSR
|
|
|
|
|
|
For Period Ended:
|
October 31, 2019
|
¨
Transition Report on Form 10-K
¨
Transition Report on Form 20-F
¨
Transition Report on Form 11-K
¨
Transition Report on Form 10-Q
¨
Transition Report on Form N-CEN
For The Transition Period Ended:
|
|
Read Instruction (on back page) Before
Preparing Form. Please Print or Type.
Nothing in this form shall be
construed to imply that the Commission has verified any information contained herein.
|
If the notification relates to a portion of the filing checked
above, identify the Item(s) to which the notification relates:
|
PART I — REGISTRANT INFORMATION
Streamline Health Solutions, Inc.
|
Full Name of Registrant
|
Former Name if Applicable
1175 Peachtree Street, NE, 10th Floor
|
Address of Principal Executive Office (Street and Number)
Atlanta, Georgia 30361
|
City, State and Zip Code
|
PART II — RULES 12b-25(b) AND (c)
If the subject report could not be filed
without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed.
(Check box if appropriate)
|
(a)
|
The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
|
x
|
(b)
|
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
|
|
(c)
|
The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART III — NARRATIVE
State below in reasonable detail the reasons
why Forms 10-K, 20-F, 11-K, 10-Q, N-CEN, or the transition report or portion thereof, could not be filed within the prescribed
time period.
Streamline Health Solutions, Inc. (the
“Company”) has determined that it is unable to file its Quarterly Report on Form 10-Q for the quarterly period
ended October 31, 2019 (its “Form 10-Q”) within the time period required for the reasons specified below.
As previously disclosed, in preparation
of the Company’s financial statements for the third quarter ended October 31, 2019, the Company discovered certain software
projects underlying its “Capitalized Software Development” asset were not appropriately amortized and the corresponding
amortization expenses and net Capitalized Software Development asset balance were not correct in the Company’s consolidated
financial statements for fiscal year 2018 and for the first half of fiscal year 2019. The Company is currently working to resolve
this issue and to determine the need to amend previously filed financial statements. As a result of this discovery, the Company
encountered a delay in the assembly and review of the consolidated financial information for the period ended October 31, 2019,
which delay could not be eliminated.
In accordance with Rule 12b-25 of
the U.S. Securities Exchange Act of 1934, as amended, the Company expects to file its Form 10-Q no later than the fifth calendar
day following the prescribed due date.
PART IV — OTHER
INFORMATION
|
|
(1)
|
Name and telephone number of person to contact in regard to this notification:
|
|
|
|
Thomas J. Gibson
|
|
(888)
|
|
997-8732
|
|
(Name)
|
|
(Area Code)
|
|
(Telephone Number)
|
|
|
|
|
|
|
(2)
|
Have
all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the
Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to
file such report(s) been filed? If answer is no, identify report(s). Yes x
No ¨
|
|
|
(3)
|
Is
it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year
will be reflected by the earnings statements to be included in the subject report or portion thereof? Yes ¨
No x
|
|
|
|
|
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of results cannot be made.
|
|
|
|
|
|
|
|
|
Streamline Health Solutions, Inc.
|
|
(Name of Registrant as Specified in Charter)
|
|
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
|
Date:
|
December 16, 2019
|
|
By:
|
/s/ Thomas J. Gibson
|
|
|
Thomas J. Gibson, Senior Vice President, Chief Financial Officer
|
INSTRUCTION: The form may be signed by
an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing
the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized
representative (other than an executive officer), evidence of the representative's authority to sign on behalf of the registrant
shall be filed with the form.
|
ATTENTION
|
|
Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).
|
Streamline Health Soluti... (NASDAQ:STRM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Streamline Health Soluti... (NASDAQ:STRM)
Historical Stock Chart
From Apr 2023 to Apr 2024